Impact of real-time antimicrobial stewardship team intervention versus conventional microbiology reporting on time to appropriate antimicrobial therapy in patients with Enterobacterales bacteremia by King, Scott C et al.
Providence St. Joseph Health 
Providence St. Joseph Health Digital Commons 
Providence Pharmacy PGY1 Program at 
Providence Portland and Providence St. Vincent 
Medical Centers 
Oregon Academic Achievement 
4-29-2020 
Impact of real-time antimicrobial stewardship team intervention 
versus conventional microbiology reporting on time to appropriate 
antimicrobial therapy in patients with Enterobacterales 
bacteremia 
Scott C. King 
Providence St. Vincent Medical Center, Scott.King2@providence.org 
Alyssa B Christensen 
Providence St. Vincent Medical Center, alyssa.christensen@providence.org 
Brent Footer 
Providence Health and Services, Portland, OR, USA., brent.footer@providence.org 
Timothy G. Shan 
Providence St. Vincent Medical Center, Tim.Shan@providence.org 
Kim Health 
Providence St. Joseph Health 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.psjhealth.org/pharmacy_PGY1 
 Part of the Pharmacy and Pharmaceutical Sciences Commons 
Recommended Citation 
King, Scott C.; Christensen, Alyssa B; Footer, Brent; Shan, Timothy G.; Health, Kim; Thomas, Ivor; and 
Oethinger, Margaret, "Impact of real-time antimicrobial stewardship team intervention versus conventional 
microbiology reporting on time to appropriate antimicrobial therapy in patients with Enterobacterales 
bacteremia" (2020). Providence Pharmacy PGY1 Program at Providence Portland and Providence St. 
Vincent Medical Centers. 5. 
https://digitalcommons.psjhealth.org/pharmacy_PGY1/5 
This Poster is brought to you for free and open access by the Oregon Academic Achievement at Providence St. 
Joseph Health Digital Commons. It has been accepted for inclusion in Providence Pharmacy PGY1 Program at 
Providence Portland and Providence St. Vincent Medical Centers by an authorized administrator of Providence St. 
Joseph Health Digital Commons. For more information, please contact digitalcommons@providence.org. 
Authors 
Scott C. King, Alyssa B Christensen, Brent Footer, Timothy G. Shan, Kim Health, Ivor Thomas, and 
Margaret Oethinger 
This poster is available at Providence St. Joseph Health Digital Commons: https://digitalcommons.psjhealth.org/
pharmacy_PGY1/5 
Labs on 
admission:
Impact of real-time antimicrobial stewardship team intervention versus conventional microbiology reporting 
on time to appropriate antimicrobial therapy in patients with Enterobacterales bacteremia
Scott C. King, PharmD, BSN, Alyssa B. Christensen PharmD, BCIDP, Brent W. Footer, PharmD, BCPS, Timothy G. 
Shan, PharmD Candidate 2020, Kim Health, MT(ASCP), Ivor Thomas, MT, and Margret Oethinger MD, PhD
Background
Objectives
Discussion
Conclusions
Disclosure
Patient Population Studied Clinical Outcomes
Clinical Outcomes (continued)
Study Design
• Retrospective, multi-center, matched, pre- and post-
quasi-experimental study conducted at eight acute 
care hospitals in the Providence Health & Services 
Oregon region between August 2018 and June 2019
Inclusion criteria
• Adults (>18 yo), non-pregnant
• Enterobacterales BSI
• On broad spectrum therapy (IV anti-pseudomonal
therapy)
• Source control achieved within 5 days of positive 
culture result
• Taking other enteral meds or food by day 5
• Pitt bacteremia score of <1 by day 5
• Availability of an in vitro active oral agent
Exclusion criteria
• Patients transferred from an outside hospital
• Polymicrobial bacteremia
• Patients who expire before blood cultures results 
were reported
• Patients on hospice/comfort care
• Patients who transfer to a non-Providence hospital
Primary outcome
• Time to de-escalation from broad spectrum therapy
Secondary outcome
• Hospital length of stay
• Total duration of antibiotic therapy
Patient Population
• A total of 60 patients were include in this study: 30 
patients in the pre-intervention group and 30 
patients in the post-intervention group. 
• The most common age group was patients 60-69 
years of age (43% vs 43%)
• The most common causative organism for the BSI 
was found to be Escherichia coli (76.7% vs 50%,) 
Clinical Outcomes
• During the intervention period a decrease was noted 
in median time to de-escalation of therapy in the 
non-ICU groups (2.7 days vs 1.8 days, p=0.0221)
• A decrease in length of stay was also noted in the 
length of stay in the non-ICU groups (5 days vs 4.1 
days, p=0.047)
• There was no statistical difference in the total length 
of therapy (combined inpatient and outpatient 
duration) between the Non-ICU groups (10 days vs 9 
days, p=0.8379)
Study Limitations
• Non-randomized
• Different time periods and providers in pre-
post-intervention groups
• Small sample size
• Did not match by organism
• Did not analyze percentage of interventions accepted
• Kochanek K.D., Murphy S.L., Xu J,m et al. National Center for Health Statistics. 2019. Deaths: final 
data for 2017. National Vital Statistics Reports; vol 68, no.9. National Center for Health Statistics, 
Hyattsville, MD.
• Tansarli G.S., Andreatos N., Pliakos E.E., et al. A systematic review and meta-analusis of antibiotic 
treatment duration for bactermia due to Enterobacteriaceas. Antimicrob. 2019;63(5):e02495-02518.
• Huang A.M, Newton D., Kunapuli A., et al. Impact of rapid organism identification via matrix-assisted 
laser desorption/ionization time-of-flight combined with antimicrobial stewardship team 
intervention in adult patients with bacteremia and candidemia. Clin Infect Dis. 2013;57(9):1237-
1245.
• Messacar K., Parker S.K, Todd J.K., et al. Implementation of rapid molecular infectious disease 
diagnostics: the role of diagnostic and antimicrobial stewardship. J Clin Microbiol. 2017;55(3):715-
723.
• Blood stream infections remain a major cause of 
mortality in the United States1 and the world2
• Previous literature have established that rapid 
diagnostics with real time interventions lead to 
superior outcomes vs passive notification3, 4
• The Providence Oregon region conducts direct from 
blood culture (DFB) matrix-assisted laser 
desorption/ionization time of flight (MALDI-TOF)   
identification, which results in decreased time to 
organism identification
• In February 2019, the antimicrobial stewardship 
team (AMT) established a real-time alert and clinical 
intervention for positive blood cultures identified by 
DFB MALDI-TOF
Table 2. Patient outcomes
• With the rapid real time results and AMT 
interventions there was a decrease in time to de-
escalation
• This reinforces conclusions from previous studies
• There was also a decrease in length of hospital stay 
between the two groups
• No difference was found between the two groups in 
regards to total length on antibiotic therapy
• There was no noted significance in the difference in 
time to PO between the groups. A larger study could 
help to identify if this is true.
• This study helps to highlight the significant impact of 
an AMT can have on patient outcomes, and the cost 
savings that can be achieved through antimicrobial 
stewardship
Purpose
• Assess the impact of MALDI-TOF identification, 
combined with real time notification and AMT 
intervention, has on clinical outcomes in patients 
with Enterobacterales blood stream infections (BSI)
Methodology
• Identify and match patient pairs with 
Enterobacterales BSI from the study time frame
• Evaluate the time to de-escalation therapy, length of 
hospitalization, and total length of antibiotic therapy
• Assess the effect the AMT has on clinical outcomes 
in the post-intervention group
Results
Characteristic Pre Group 
(n=30)
Post Group 
(n=30)
p-value
Age, No. (%) 1
20-59 8 (27) 8(27)
60-69 13 (43) 13 (43)
>70 9 (30) 9 (30)
Sex, female, No. 
(%)
23 (76.7) 22 (73.3)
Organism, No. (%) 0.0321
E. coli 23 (76.7) 15 (50)
Non E. coli 7 (23) 15 (50)
Pitt Bacteremia Score, No. (%) 0.1172
Score of 0 21 (70) 26 (86.7)
Score of 1 9 (30) 4 (13.3)
Location, No. (%) 0.7656
Non-ICU 27 (77) 22 (73)
ICU 7 (23) 8 (27)
Discharge Antibiotics, No. (%) ---
Levofloxacin 2 (6.7) 2 (6.7)
Cefpodoxime 0 (0) 1 (3.33)
Ciprofloxacin 9 (30) 8 (26.7) 
Cefuroxime 0 (0) 1 (3.33)
Cefdinir 0 (0) 3 (10)
Amoxicillin 1 (3.33) 1 (3.33)
Trimethoprim-
sulfamethoxazole
2 (6.7) 4 (13.3)
Cephalexin 7 (23.3) 5 (16.7)
Amoxicillin-
clavulanate
4(13.3) 4 (13.3)
No antibiotics 5 (16.7) 1 (3.33)
Outcomes, days Pre Group 
(n=30)
Post Group 
(n=30)
p-value
Time to de-
escalation
2.7 1.8 0.0061
Length of stay 5.3 4.3 0.0475
Length of Therapy, days
Inpatient 4 4 0.1982
Outpatient 7 7 0.7772
Total 9 9.5 1
Non-ICU 
outcomes, days
Pre Group 
(n=23)
Post Group 
(n=22)
p-value
Time to de-
escalation
2.7 1.8 0.0221
Length of stay 5 4.1 0.047
Time to Oral 3.8 2.9 0.0832
Length of Therapy, days
Inpatient 4 3.5 0.2228
Outpatient 7 7 0.9546
Total 10 9 0.8379
ICU outcomes,
days
Pre Group 
(n=7)
Post Group 
(n=8)
p-value
Time to de-
escalation
2.2 1.9 0.2045
Length of stay 7.3 5.6 0.2901
Time to Oral 5 3.6 0.4166
Length of Therapy, days
Inpatient 7 5 0.3643
Outpatient 5 5.5 0.7327
Total 9 10.5 0.6476
Outcome Group (n=***) Group (n=***)
Health & Services
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